RECOMMENDED PRODUCTS
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 20259 | Elinzanetant ( NT-814 ) | 929046-33-3 | ≧98.0% |  |
| Elinzanetant, previously known as NT-814 (45), is a dual NK1,3R antagonist and theref | ||||
| 20368 | SHMT-IN-2 | 2102681-49-0 | ≧98.0% |  |
| SHMT-IN-2 is a serine hydroxymethyltransferase (SHMT) inhibitor, potently inhibiting | ||||
| 1711225 | Fosgonimeton (ATH-1017) | 2093305-05-4 | ≧98.0% | _2093305-05-4.png) |
| Fosgonimeton (ATH-1017) is a small molecule designed to enhance the activity of hepat | ||||
| 18435 | Ritlecitinib ( PF-06651600 ) | 1792180-81-4 | ≧98.0% | _1792180-81-4.png) |
| Ritlecitinib ( PF-06651600 ) is a potent and selective JAK3 inhibitor. PF-06651600, a | ||||
| 20344 | SMN-C3 | 1449597-34-5 | ≧98.0% |  |
| SMN-C3is an orally active SMN2 splicing modulator and has the potential to treat spin | ||||
| 226191 | AGN 196996 | 958295-17-5 | ≧98.0% |  |
| AGN 196996 is a potent and selective RARα antagonist with Ki value of 2 nM; little b | ||||
| 20369 | Sunvozertinib ( DZD 9008 ) | 2370013-12-8 | ≧98.0% | _2370013-12-8.png) |
| Sunvozertinib, also known as DZD9008, is an oral, potent, irreversible, and selective | ||||
| 822222 | SEP-363856 HCl ( SEP-856 ) | 1310422-41-3 (HCl) | ≧98.0% | .png) |
| SEP-363856 is a novel trace amine receptor 1 (TAAR1) agonist with serotonin 5-HT1A ac | ||||
| 61726 | Ensifentrine ( RPL554 ) | 1884461-72-6 | ≧98.0% | _1884461-72-6.png) |
| Ensifentrine (RPL554) is an investigational, first-in-class, inhaled dual inhibitor o | ||||
| 822221 | BBP-398 ( IACS-13909 ) | 2160546-07-4 | ≧98.0% | _2160546-07-4.png) |
| BBP-398 is a potent and selective SHP2 inhibitor that demonstrates pathway inhibition | ||||
| 20281 | ABT-384 | 868623-40-9 | ≧98.0% |  |
| ABT-384 is a potent and selective inhibitor of 11β-hydroxysteroid dehydrogenase type | ||||
| 21224 | BI-187004 | 1303515-32-3 | ≧98.0% |  |
| BI-187004, also known as VTP-34072, is an 11β-hydroxysteroid dehydrogenase 1 inhibit | ||||